Adult cardiovascular surgery and the coronavirus disease 2019 (COVID-19) pandemic: the Italian experience

Interact Cardiovasc Thorac Surg. 2020 Dec 7;31(6):755-762. doi: 10.1093/icvts/ivaa186.

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has profoundly affected all health care professionals. The outbreak required a thorough reorganization of the Italian regional local health care system to preserve resources such as ventilators, beds in intensive care units and surgical and anaesthesiological staff. Levels of priority were created, together with a rigorous triage procedure for patients with COVID-19, which led to postponement of all elective procedures. Urgent cases were discussed with the local heart team and percutaneous approaches were selected as the first treatment option to reduce hospital stay. COVID-19 and COVID-19-free pathways were created, including adequate preparation of the operating room, management of anaesthesiological procedures, transportation of patients and disinfection. It was determined that patients with chronic diseases were at increased risk of adverse outcomes. Systemic inflammation, cytokine storm and hypercoagulability associated with COVID-19 increased the risk of heart failure and cardiac death. In this regard, the early use of extracorporeal membrane oxygenation could be life-saving in patients with severe forms of acute respiratory distress syndrome or refractory heart failure. The goal of this paper was to report the Italian experience during the COVID-19 pandemic in the setting of cardiovascular surgery.

Keywords: Cardiac surgery; Coronavirus disease 2019; Extracorporeal membrane oxygenation; Personal protective equipment; Vascular Surgery.

Publication types

  • Systematic Review

MeSH terms

  • COVID-19 / epidemiology*
  • Cardiac Surgical Procedures / methods*
  • Comorbidity
  • Extracorporeal Membrane Oxygenation / methods*
  • Heart Failure / epidemiology
  • Heart Failure / surgery*
  • Humans
  • Intensive Care Units
  • Italy / epidemiology
  • Pandemics*
  • SARS-CoV-2*